The Atlanta Braves are navigating a tricky landscape as they seek to bolster their starting rotation in 2026. Injuries to key pitchers Hurston Waldrep, Spencer Schwellenbach, and Joey Wentz have left the team in need of reinforcements. Despite offseason efforts to secure additional starters, the market hasn't unfolded in their favor, leaving them to explore short-term solutions and potential in-season trades.
Jurickson Profar's suspension might inadvertently provide some financial flexibility. If his suspension is upheld, the Braves won't have to pay his $15 million salary this season. This could free up funds to address their pitching needs, but the team is cautious about spending until the suspension is confirmed.
With the trade deadline approaching, General Manager Alex Anthopoulos is likely preparing for strategic moves. If the Braves remain competitive, expect Anthopoulos to be active, particularly in seeking pitching talent. However, speculation about acquiring Sandy Alcantara from the Marlins seems far-fetched.
Alcantara, a former Cy Young winner, naturally draws interest. Yet, his post-Tommy John surgery performance has seen a dip in key metrics, aside from his fastball velocity. The Braves would face a steep price, especially given the in-division dynamics with the Marlins.
Timing further complicates matters. Atlanta needs immediate pitching support, while the Marlins aren't keen on trading Alcantara just yet. By the time he might be available, the Braves could have Schwellenbach and Waldrep back in action, reducing the urgency for a high-cost trade.
Alcantara's contract includes a 2027 club option, adding a layer of intrigue due to the potential for extended team control. However, this also increases his trade value, making an already unlikely in-division deal even more improbable.
In essence, while the Braves have options and a potential financial cushion, navigating the trade market will require careful strategy and timing.